Aspen Strikes Deal With India’s Laurus to Cut Cost of HIV Drugs

Operations at the Laurus Labs Ltd. Manufacturing Facility

Photographer: Sara Hylton/Bloomberg

Aspen Pharmacare Holdings Ltd.
agreed to a partnership with India’s Laurus Labs Ltd. to boost supply of active pharmaceutical ingredients that will help reduce the cost of HIV drugs.

The Durban-based company plans to license intellectual property rights owned by Laurus, executive Stavros Nicolaou said by phone on Friday. The Indian company will gain a trading entity in South Africa as part of the deal, he said.

The move will put Aspen in a better position to bid for government contracts as the country plans to scale up treatment to 6 million people, Nicolaou said. The deal was first reported by Business Day newspaper.

The shares rose 1.3% in early trade in Johannesburg.

Original Source

Leave a Reply

Your email address will not be published. Required fields are marked *